<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>
<channel>
	<title>Comments on: XenoPort Reports Positive Results From A Phase 2 Trial Of Arbaclofen Placarbil In Spinal Cord Injury Patients With Spasticity</title>
	<atom:link href="http://discusspharmacy.com/2009/07/xenoport-reports-positive-results-from-a-phase-2-trial-of-arbaclofen-placarbil-in-spinal-cord-injury-patients-with-spasticity/feed/" rel="self" type="application/rss+xml" />
	<link>http://discusspharmacy.com/2009/07/xenoport-reports-positive-results-from-a-phase-2-trial-of-arbaclofen-placarbil-in-spinal-cord-injury-patients-with-spasticity/</link>
	<description>Blog for discussing pharmacy drugs and new developments in pharmacy</description>
	<pubDate>Sun, 01 Aug 2010 08:26:21 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	</channel>
</rss>
